N-Zyme Raises $4.6 Million to Fund Mid-Stage Reflux Trials
NEWARK, DE — N-Zyme Biomedical has raised approximately $4.6 million in a Series A financing, providing enough capital to fund planned Phase 2 clinical studies of its investigational reflux therapy …
N-Zyme Raises $4.6 Million to Fund Mid-Stage Reflux Trials Read More